Commercial Credit Report for Curalogic A/S (Denmark)

Preview

This is a Preview, click here for the full commercial credit report.

Curalogic A/S
Landemaerket 11
1st floor
Phone: (99) 992-400	Copenhagen 1119 Denmark	Ticker: CUR

This company is no longer actively traded on any major stock exchange.

Business Summary

Curalogic A/S is a Denmark-based development company. It mainly focuses on drug development, project management, clinical development, quality assurance, and the development and manufacture of pharmaceuticals. The Company is not a research organization and it purchases all services related to clinical trials and product development and manufacture.

Financial Information

Financial Ratings:	Z'' Score FRISK Score
Latest Financial Statements and Analyses:	12/31/2008 Annual Financials Quarterly Financials
Current Fiscal Period:	4Q 2008
Fiscal Year End:	December
Last Audit:	12/31/2008
Auditors:	Deloitte & Touche, LLP (Deloitte Haskins & Sells)
Audit Opinion:	Unqualified

Industries

Type

Code

Description

Sector

HEALTH

Healthcare

Industry

BIOTRX

Biotechnology & Drugs

SIC

2835

In Vitro And In Vivo Diagnostic Substances

NAICS

325412

Pharmaceutical Preparation Manufacturing

Management

Title

Name

Age

Title Date

Start Date

Chairman of the Board

Jakob Schmidt

1/1/2006

Chief Executive Officer and President

Peter Moldt

Chief Financial Officer and Executive Vice President

Helle Busck Fensvig

1/1/2005

5 additional Management records available in full report.

General Information

Number of Employees:	8	(As of 12/31/2008)
Outstanding Shares:	56,480,149	(As of 12/31/2008)
Shareholders:	3,173	(As of 12/31/2008)
Stock Exchange:	CPH
Fax Number:	(99) 992-424